Table 1 Demographical and clinical futures of patients
Baseline characteristics | Malignancies (n = 75) | No malignancies (n = 111) | P values |
|---|---|---|---|
Age, y | 64.69 ± 12.98 | 64.81 ± 6.35 | NS |
Sex, f/m | 28/47 | 41/70 | NS |
O2 support, L/per min | 4.72 ± 7.25 | 2.36 ± 3.92 | = 0.005 |
SpO2, under oxygen support; median | 93.95 ± 2.11 | 94.26 ± 1.86 | NS |
Respiratory rate, per minute | 21.65 ± 5.44 | 18.76 ± 3.69 | < 0.001 |
Body temperature, °C | 37.0 ± 0.80 | 36.93 ± 0.66 | NS |
Systolic blood pressure, mmHg | 126.87 ± 20.21 | 127.95 ± 18.16 | NS |
Diastolic blood pressure, mmHg | 68.64 ± 10.29 | 70.98 ± 10.02 | NS |
Heart rate, per minute | 85.05 ± 16.47 | 81.65 ± 12.81 | NS |
Arterial hypertension on treatment | 33 (44%) | 50 (45%) | NS |
Diabetes mellitus on treatment | 20 (26.7%) | 21 (18.9%) | NS |
Chronic atrial fibrillation | 2 (2.7%) | 5 (4.5%) | NS |
Heart failure | 2 (2.7%) | 9 (8.1%) | NS |
Prior coronary artery disease | 8 (10.7%) | 24 (21.6%) | NS |
Prior stroke | 6 (8%) | 7 (6.3%) | NS |
Chronic obstructive pulmonary disease | 7 (9.3%) | 5 (4.5%) | NS |
Asthma bronchiale | 3 (4%) | 13 (11.7%) | NS |
Chronic kidney disease | 4 (5.3%) | 6 (5.4%) | NS |
CT results (n, %) | NS | ||
Mild involvement | 14 (%18.6) | 27 (%24.3) | |
Moderate involvement | 39 (%52) | 60 (%54) | |
Severe involvement | 22 (%29.4) | 24 (%21.7) | |
Disease Status (n, %) | NS | ||
Moderate | 31 (%41.3) | 57 (%51.4) | |
Severe | 44 (%58.7) | 54 (%48.6) |